| 恶性肿瘤与胰岛素抵抗 |
| |
| 引用本文： | 张怡梅,刘斌,任朝英,李书君,贾漪涛,李庆霞. 恶性肿瘤与胰岛素抵抗[J]. 中华肿瘤防治杂志, 2003, 10(1): 24-26 |
| |
| 作者姓名： | 张怡梅 刘斌 任朝英 李书君 贾漪涛 李庆霞 |
| |
| 作者单位： | 白求恩国际和平医院肿瘤科,河北石家庄,050082;河北省人民医院肿瘤科,河北石家庄,050051 |
| |
| 摘 要： | 恶性肿瘤患者存在胰岛素抵抗(insulin resistance,IR),同时IR又是引起恶性肿瘤发生的诱因之一。监测恶性肿瘤患者中IR水平,有助于提高对肿瘤疗效及预后的判断,并有助于预防肿瘤。
|
| 关 键 词： | 胰岛素抗药性 肿瘤 |
| 文章编号： | 1009-4571(2003)01-0024-03 |
| 修稿时间： | 2001-08-20 |
Malignancy and Insulin Resistance |
| |
| ZHANG Yi-mei,LIU Bin,REN Chao-ying,et al.. Malignancy and Insulin Resistance[J]. Chinese Journal of Cancer Prevention and Treatment, 2003, 10(1): 24-26 |
| |
| Authors: | ZHANG Yi-mei LIU Bin REN Chao-ying et al. |
| |
| Affiliation: | ZHANG Yi-mei,LIU Bin,REN Chao-ying,et al. Department of Medicine Oncology,Bethune International Peace Hospital,Shijiazhuang 050082,China |
| |
| Abstract: | Insulin resistance (IR) exists in tumor, and also is one of the pathogenic factors. Furthermore, the expression of IR in tumor is helpful for disease outcome, the evaluation of prognosis, and prevention of tumor. |
| |
| Keywords: | insulin resistance neoplasms |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
